Related Experiment Videos
PHLS mycobacteriology reference services in England and Wales
F A Drobniewski1, J G Magee, E G Smith
1PHLS Mycobacterium Reference Unit, Dulwich Public Health Laboratory, Dulwich Hospital, London.
Communicable Disease Report. CDR Review
|July 25, 1997
Summary
Tuberculosis (TB) reference services have been enhanced to combat rising drug resistance. Advanced diagnostics, including molecular DNA analysis and drug susceptibility testing, improve global surveillance and patient care for this infectious disease.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) remains a leading global infectious disease with increasing incidence and drug resistance.
- Nosocomial outbreaks of drug-sensitive and drug-resistant TB necessitate enhanced public health response.
- The Public Health Laboratory Service (PHLS) prioritizes TB control and surveillance.
Purpose of the Study:
- To review the enhanced mycobacteriology reference services provided by the PHLS in England and Wales.
- To highlight advancements in diagnostic and surveillance capabilities for TB.
- To underscore the role of reference services in combating drug-resistant TB.
Main Methods:
- Microscopy and culture on solid and liquid media.
- Rapid culture systems and identification using phenotypic characteristics.
- Molecular DNA analysis, including rapid DNA amplification techniques.
- Drug susceptibility testing of isolates by PHLS Regional Centres.
Main Results:
- The Mycobacterium Reference Unit (MRU) offers rapid molecular identification of Mycobacterium tuberculosis.
- All four PHLS Regional Centres perform drug susceptibility testing.
- MRU serves as a World Health Organisation reference centre for global TB drug resistance surveillance.
- The 'Mycobnet' surveillance scheme collates national drug resistance data.
Conclusions:
- Enhanced reference services, including advanced diagnostics and surveillance, are crucial for TB control.
- The MRU and PHLS collaborate effectively for national and global TB drug resistance monitoring.
- These services are vital in addressing the challenges posed by drug-resistant tuberculosis.